英文别名 |
BMS 663068;[3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1,2,4-triazol-1-yl)pyrrolo[2,3-c]pyridin-1-yl]methyl dihydrogen phosphate;BMS-663068;FOSTEMSAVIR;1-(4-Benzoyl-1-piperazinyl)-2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-ethanedione (ACI);Piperazine, 1-benzoyl-4-[[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]oxoacetyl]- (9CI);Rukobia;BMS663068;EN300-20207550;HY-15440A;1,2-Ethanedione, 1-(4-benzoyl-1-piperazinyl)-2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-;fostemsavir & CH106;DTXSID40235596;BMS-663068 free acid;BMS-626529 & PG16-iMab;Fostemsavir(BMS-663068);AC-30663;fostemsavir & 3BNC117;({3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-1-yl}methoxy)phosphonic acid;Fostemsavir; BMS-663068;[3-[2-(4-benzoylpiperazin-1-yl)-2-oxo-acetyl]-4-methoxy-7-(3-methyl-1,2,4-triazol-1-yl)pyrrolo[2,3-c]pyridin-1-yl]methyl dihydrogen phosphate;864953-29-7;fostemsavir & 4Dm2m;Fostemsavir (USAN);(3-(2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-1-yl)methyl dihydrogen phosphate;fostemsavir & NIH45-46G54W;NCGC00510187-01;864953-29-7(free base);FOSTEMSAVIR [MI];Fostemsavir(BMS-663068)?;Piperazine, 1-benzoyl-4-((4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-((phosphonooxy)methyl)-1H-pyrrolo(2,3-c)pyridin-3-yl)oxoacetyl)-;BMS-626529 & PG16;97IQ273H4L;BMS-626529 & 35O22;fostemsavir & N6;fostemsavir & VRC03;fostemsavir & PGT128;UNII-97IQ273H4L;BMS-626529 & PGT128-iMab;BMS-626529 & 3BNC117;BMS-626529 & VRC07-523;D10707;BMS-626529 & PGT128;fostemsavir & PG16-iMab;FOSTEMSAVIR [INN];DB11796;BMS626-529 & VRC03;FOSTEMSAVIR [WHO-DD];compound 35 [PMID: 29271653];s7220;GTPL11100;CS-1059;BMS-626529 & CH106;1,2-Ethanedione, 1-(4-benzoyl-1-piperazinyl)-2-(4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-((phosphonooxy)methyl)-1H-pyrrolo(2,3-c)pyridin-3-yl)-;(3-((4-Benzoyl-1-piperazinyl)(oxo)acetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo(2,3-c)pyridin-1-yl)methyl dihydrogen phosphate;GSK3684934;BMS-626529 & N6;Fostemsavir [USAN];(3-((4-BENZOYLPIPERAZIN-1-YL)-OXOACETYL)-4-METHOXY- 7-(3-METHYL-1H-1,2,4-TRIAZOL-1-YL)-1H-PYRROLO(2,3-C)PYRIDIN- 1-YL)METHYL DIHYDROGEN PHOSPHATE;fostemsavir & VRC07-523;FTR;BMS-626529 & 4Dm2m;EX-A1973;NS00071059;AKOS025396430;SB11250;CHEMBL3301594;SCHEMBL754395;GSK-3684934;BCP13226;fostemsavir & PG16;Q17001240;BMS626-529 & NIH45-46G54W;fostemsavir & 35O22;fostemsavir & PGT128-iMab |